ALT Altimmune Inc
Company Analysis
Latest News
🟢 Altimmune is trading 7.6% up in pre-market as its cause remains unclear
Altimmune is trading at $2.34, up 7.64%, with no confirmed catalyst for its October 23 pre-market move. - No fresh company announcement explaining the move...
🔴 Altimmune is trading 5% down today as biotech shares face pressure
Altimmune is trading at $2.24, down -5.08%, amid broader biotech weakness. - No new company-specific catalyst was detected for Altimmune on October 16;...
🔴 Altimmune is trading 5% down on October 14, 2026, with no specific catalyst confirmed
Altimmune is trading at $2.31, down 5.14%, with no new company-specific headline identified for October 14. - Broad market pressure followed...
🔴 Altimmune is trading 5.5% down today as rising Treasury yields pressure growth stocks
Altimmune is trading 5.5% down at $3.02 amid broad risk-off sentiment weighing on growth-oriented stocks. - Elevated Treasury yields, inflation concerns and a...
🔴 Altimmune is trading 5.36% down today amid broad market risk-off pressure
Altimmune is trading 5.36% lower at $3.23, with the decline appearing primarily linked to broad risk-off conditions. - The Nasdaq Composite is down 1.03%,...
🟢 Altimmune is trading 5.3% up today
Altimmune is trading 5.26% higher at $3.40, with no clear company-specific catalyst identified. - The latest official announcement, dated September 3,...
🟢 Altimmune is trading 5% up today as biotech shares strengthen
Altimmune is trading 5.02% higher at $3.25, with biotech-sector strength the clearest explanation after no new company-specific announcement was identified for...
🔴 Altimmune is trading 5.25% down today amid biotech weakness ahead of Warsh speech
Altimmune is trading 5.25% down now at $3.07, primarily amid broader biotech weakness as investors reduce exposure to growth-oriented biotechnology ahead of...